pioglitazone has been researched along with ephedrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gettys, T; Hughes, TA; Smith, SR; Stentz, F | 1 |
| Bogacka, I; de Jonge, L; Gettys, TW; Greenway, F; Nguyen, T; Smith, JM; Smith, SR; Xie, H | 1 |
1 review(s) available for pioglitazone and ephedrine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for pioglitazone and ephedrine
| Article | Year |
|---|---|
Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Apolipoproteins; Caffeine; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclic AMP; Double-Blind Method; Drug Synergism; Ephedrine; Female; Humans; Hypoglycemic Agents; Lipoproteins; Male; Middle Aged; Obesity; Phosphodiesterase Inhibitors; Pioglitazone; PPAR gamma; Prospective Studies; Thiazolidinediones; Triglycerides; Ultracentrifugation | 2006 |
The effect of beta-adrenergic and peroxisome proliferator-activated receptor-gamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue.
Topics: Adipose Tissue; Adolescent; Adult; Body Mass Index; Caffeine; Ephedrine; Female; Humans; Lipids; Male; Middle Aged; Pioglitazone; Placebos; PPAR gamma; Receptors, Adrenergic, beta; Reference Values; Skin; Thiazolidinediones | 2007 |